ResourceLife Sciences
The role of automation in liquid biopsy
14 May 2024Liquid biopsies hold significant potential in advancing oncology practices. Tecan outlines the significance of liquid biopsy in clinical diagnostics, focusing on its application in non-invasive testing like non-invasive prenatal testing (NIPT) and cancer detection. Tecan also discusses the liquid biopsy workflow, emphasizing the importance of sample preparation and the challenges associated with each step, and the role of automation in optimizing the workflow. Additionally, Tecan addresses other considerations such as assay development, scalability of chemistries, and critical steps for automation.
Links
Tags
BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :Bioprocessing / FermentationBioprocessing is the use of biological materials to perform commercial, scientific or medical research processes. Biological materials used include cells, enzymes and organisms. Usually bioprocessing requires a batch or continuous bioreactor such as a fermentor or cell culture system. The advantages of using a reactor include high productivity, easy configuration, adjustable values and automation.Liquid BiopsiesLiquid biopsies are non-invasive tests used to detect cancer and other diseases by analyzing blood or other bodily fluids. This technique is gaining popularity for early detection, monitoring treatment response, and detecting minimal residual disease. Explore liquid biopsy solutions in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Cancer ResearchAlthough cancer is often referred to as a single condition, it actually consists of more than 100 different diseases. Microscopy, mass spectrometry, high throughput sequencing and flow cytometry are some of the most common techniques employed in cancer research labs.